Available
Specifications
Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc.
Active ingredient:
Shelf life: Usually 2–3 years (24–36 months) from the date of production, subject to storage conditions (specified on the packaging).
Current price
$41
Place an order
Want to find several options? Our manager will clarify all the details of your order and choose a convenient delivery option
Delivery and self-delivery
Storage conditions
Store at a temperature not exceeding 25°C, in a dry place, protected from light and moisture.
Store in the original packaging.
Keep out of reach of children.
Mexitil is the trade name for a medication containing mexiletine, a class IB antiarrhythmic agent. It is used for the treatment and prevention of various cardiac rhythm disorders.
Indications for Use:
- Ventricular Arrhythmias:
- Treatment and prevention of symptomatic ventricular arrhythmias, including ventricular tachycardia.
- Supraventricular Arrhythmias:
- For cases where other treatment options are ineffective or contraindicated.
Contraindications:
- Known hypersensitivity to mexiletine or any components of the drug.
- Cardiogenic Shock.
- Sick Sinus Syndrome, unless a pacemaker is present.
- Second- or Third-Degree Atrioventricular Block, unless the patient has a pacemaker.
- Severe bradycardia.
Side Effects:
- Central Nervous System:
- Dizziness, tremor, blurred vision, headache, nervousness, drowsiness.
- Gastrointestinal System:
- Nausea, vomiting, heartburn, abdominal pain.
- Cardiovascular System:
- Hypotension, worsening of arrhythmias, bradycardia.
- Allergic Reactions:
- Skin rash, pruritus (itching).
Special Instructions:
- Therapy Monitoring:
- Regular monitoring of ECG and plasma mexiletine levels is recommended to optimize dosage and minimize the risk of side effects.
- Hepatic and Renal Impairment:
- In patients with liver or kidney dysfunction, dose adjustments and careful monitoring are necessary.
- Drug Interactions:
- Mexiletine may interact with other antiarrhythmic agents, beta-blockers, and CYP2D6 inhibitors. Use caution when combining therapies.
- Pregnancy and Lactation:
- Use is permitted only under strict medical indications and supervision.
- Consultation Recommended:
- Before initiating treatment with Mexitil, consult a healthcare provider to evaluate the appropriateness of therapy and determine the optimal dosage. Self-medication is not advised and may result in adverse effects.
- Oral capsules, 100 mg.
- There may also be 150 mg and 200 mg forms (depending on country and clinical indication).
- Extended-release capsules are also available in some markets.
